Trial intelligence / Profile preview

Wound Infiltration vs Epidural for Pain After Hip Arthroplasty

NCT00289419Phase 4Completed

Sponsor
Aarhus University
Start
Feb 2005
Primary completion
Feb 2006
Modality
Recombinant Proteins and Enzymes, Targeted Liposomes, Stealth (PEGylated) Liposomes
Countries
1
01

Overview

Phase 4, randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection, ketorolac and epinephrine in postoperative pain (2 arms), sponsored by Aarhus University. Primary endpoint: Consumption of analgesics at 96 hours. Started Feb 2005; status: completed.

02

Drugs

ropivacaine hydrochloride liposomal suspension injectionketorolacepinephrine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT00289419.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00289419.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call